Alimentary Pharmacology & Therapeutics

Is clinical remission the optimum therapeutic goal in the treatment of Crohn's disease?
pp. 857-867(11)
Authors: Arnott, I. D. R.; Watts, D.; Ghosh, S.

Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease
pp. 869-873(5)
Authors: Cange, L.; Johnsson, E.; Rydholm, H.; Lehmann, A.; Finizia, C.; Lundell, L.; Ruth, M.

A modification of the quininium resin test for assessing gastric acidity
pp. 875-880(6)
Authors: Passaro, D. J.; Hurwitz, A.; Triadafilopoulos, G.; Parsonnet, J.

Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression
pp. 881-886(6)
Authors: Frazzoni, M.; De Micheli, E.; Grisendi, A.; Savarino, V.

Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus
pp. 887-891(5)
Authors: Laheij, R. J. F.; Van Rossum, L. G. M.; De Boer, W. A.; Jansen, J. B. M. J.

Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus
pp. 893-898(6)
Authors: Zentilin, P.; Conio, M.; Mele, M. R.; Mansi, C.; Pandolfo, N.; Dulbecco, P.; Gambaro, C.; Tessieri, L.; Iiritano, E.; Bilardi, C.; Biagini, R.; Vigneri, S.; Savarino, V.

Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux
pp. 899-907(9)
Authors: Orenstein, S. R.; Blumer, J. L.; Faessel, H. M.; McGuire, J. A.; Fung, K.; Li, B. U. K.; Lavine, J. E.; Grunow, J. E.; Treem, W. R.; Ciociola, A. A.

Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis
pp. 909-917(9)
Authors: Mimura, T.; Rizzello, F.; Helwig, U.; Poggioli, G.; Schreiber, S.; Talbot, I. C.; Nicholls, R. J.; Gionchetti, P.; Campieri, M.; Kamm, M. A.

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride
pp. 919-927(9)
Authors: Abitbol, V.; Mary, J. Y.; Roux, C.; Soulé, J. C.; Belaiche, J.; Dupas, J. -L.; Gendre, J. P.; Lerebours, E.; Chaussade, S.

Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding?
pp. 929-936(8)
Authors: Hui, C.-K.; Lai, K.-C.; Yuen, M.-F.; Wong, W.-M.; Lam, S.-K.; Lai, C.-L.

Safety and efficacy of two reduced dosing regimens of sodium phosphate tablets for preparation prior to colonoscopy
pp. 937-944(8)
Authors: Rex, D. K.; Chasen, R.; Pochapin, M. B.

Acute effect of clonidine on gastric emptying in patients with diabetic gastropathy and controls
pp. 945-950(6)
Authors: Huilgol, V.; Evans, J.; Hellman, R. S.; Soergel, K. H.

Domperidone is more effective than cisapride in children with diabetic gastroparesis
pp. 951-957(7)
Authors: Franzese, A.; Borrelli, O.; Corrado, G.; Rea, P.; Di Nardo, G.; Grandinetti, A. L.; Dito, L.; Cucchiara, S.

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study
pp. 959-967(9)
Authors: Hallerbäck, B. I.; Bommelaer, G.; Bredberg, E.; Campbell, M.; Hellblom, M.; Lauritsen, K.; Wienbeck, M.; Holmgren, L. -L.

Perceived food and drug allergies in functional and organic gastrointestinal disorders
pp. 969-973(5)
Authors: Bhat, K.; Harper, A.; Gorard, D. A.

Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study
pp. 975-983(9)
Authors: Svedberg, P.; Johansson, S.; Wallander, M.-A.; Hamelin, B.; Pedersen, N. L.

Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself
pp. 985-992(8)
Authors: Van De Casteele, M.; Zaman, Z.; Zeegers, M.; Servaes, R.; Fevery, J.; Nevens, F.

Effect of alosetron on left colonic motility in non-constipated patients with irritable bowel syndrome and healthy volunteers
pp. 993-1002(10)
Authors: Clemens, C. H. M.; Samsom, M.; Van Berge Henegouwen, G. P.; Fabri, M.; Smout, A. J. P. M.

General principles to enhance practice patterns in gastrointestinal endoscopy
pp. 1003-1009(7)
Authors: Sonnenberg, A.; Gavin, M. W.

Prospective audit of gastroscopy under the `three-day rule': a regional initiative in Italy to reduce waiting time for suspected malignancy
pp. 1011-1014(4)
Authors: Parente, F.; Bargiggia, S.; Bianchi Porro, G.

Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy
pp. 1015-1020(6)
Authors: Palli, D.; Menegatti, M.; Masala, G.; Ricci, C.; Saieva, C.; Holton, J.; Gatta, L.; Miglioli, M.; Vaira, D.

P-Glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes
pp. 1021-1031(11)
Authors: Farrell, R. J.; Menconi, M. J.; Keates, A. C.; Kelly, C. P.

Continued utilization and costs of proton pump inhibitors after Helicobacter pylori eradication in chronic users of gastrointestinal drugs
pp. 1033-1034(2)
Authors: Klok, R. M.; Brouwers, J. R. B. J.; Van Den Berg, P. B.; De Jong-Van Den Berg, L. T. W.; Tolley, K.; Postma, M. J.

Corrigendum
pp. 1035-1035(1)